SQZ Biotechnologies (SQZ) Insider Trading & Ownership $0.02 0.00 (0.00%) (As of 11/14/2024 ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrends SQZ Biotechnologies (NYSE:SQZ) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage16.00%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$90,773.40Number OfInsiders Selling(Last 3 Years)1Amount OfInsider Selling(Last 3 Years)$3,929.40 Get SQZ Insider Trade Alerts Want to know when executives and insiders are buying or selling SQZ Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address SQZ Insider Buying and Selling by Quarter Ad Colonial Metals“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as we wait for Trump's agenda to kick in…>> YES! Send Me My FREE Gold Guide! SQZ Biotechnologies Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails8/15/2022Richard CapassoInsiderSell118$33.30$3,929.40 5/25/2022Klavs F JensenDirectorBuy1,432$35.20$50,406.40 12/13/2021Amy W SchulmanDirectorBuy370$109.10$40,367.00 (Data available from 1/1/2013 forward) SQZ Insider Trading Activity - Frequently Asked Questions Who is on SQZ Biotechnologies's Insider Roster? The list of insiders at SQZ Biotechnologies includes Amy W Schulman, Klavs F Jensen, and Richard Capasso. Learn more on insiders at SQZ. What percentage of SQZ Biotechnologies stock is owned by insiders? 16.00% of SQZ Biotechnologies stock is owned by insiders. Learn more on SQZ's insider holdings. SQZ Biotechnologies Key ExecutivesDr. Howard Bernstein M.D. (Age 66)Ph.D., Interim CEO & Director Compensation: $552.14kMr. Lawrence J. Knopf Esq. (Age 61)Gen. Counsel Compensation: $512.38kDr. Marshelle Smith Warren M.D. (Age 60)Chief Medical Officer Compensation: $476.27kDr. Robert S. Langer Jr. (Age 74)Ph.D., Sc.D., SCD, Co-Founder & Member of Scientific Advisory Board Mr. Richard V. Capasso CPA (Age 61)Chief Accounting Officer Mr. David First (Age 59)Chief People Officer Ipsita Roymoulik Ph.D.Sr. VP of CMC & QUALITY More Insider Trading Tools from MarketBeat Related Companies Air T Insider Ownership Surf Air Mobility Insider Ownership USD Partners Insider Ownership Brookfield Real Assets Income Fund Insider Ownership FLEX LNG Insider Ownership Enbridge Insider Ownership Canadian Pacific Kansas City Insider Ownership CSX Insider Ownership Mplx Insider Ownership ZTO Express (Cayman) Insider Ownership Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Insiders Bet Big on These Small Cap StocksHere’s Why Etsy Management Is Investing $1 Billion in BuybacksInsider Buying Signals Upside for These 3 StocksBig Buybacks Announced: 3 Stocks Insiders Are Banking OnInsiders Are Buying High-Yielding Delek Logistics Partners This page (NYSE:SQZ) was last updated on 11/15/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredTop "Sleeping Giant" Crypto In The Market NowTop "Sleeping Giant" Crypto In The Market Now We're looking at potential returns that could rewrite your fi...Crypto 101 Media | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredNvidia’s world of pain awaitsThe Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SQZ Biotechnologies Please log in to your account or sign up in order to add this asset to your watchlist. Share SQZ Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.